Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|July 6, 2010
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancerSrikala S Sridhar, Christina M Canil, Kim N Chi, et al.
Head & Neck Oncology|March 1, 2011
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neckNicole G Chau, Bayardo Perez-Ordonez, Katherine Zhang, et al.
Gynecologic Oncology|September 2, 2022
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinomaAinhoa Madariaga, Sandra A Mitchell, Tyler Pittman, et al.
The Oncologist|April 7, 2019
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Aaron R Hansen, Ian F Tannock, Arnoud Templeton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2017
Phase I trial of radiation therapy and sorafenib in unresectable liver metastasesRebecca B Goody, Anthony M Brade, Lisa Wang, et al.
Neuroimage|May 6, 2017
Characterization of a novel murine model for spontaneous hemorrhagic stroke using in vivo PET and MR multiparametric imagingSalvador Castaneda Vega, Christine Weinl, Carsten Calaminus, et al.
Clinical Colorectal Cancer|August 21, 2021
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal CancerKanan Alshammari, Kyaw L Aung, Tong Zhang, et al.
Cancer Medicine|October 11, 2023
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trialAlberto Hernando-Calvo, Eoghan Malone, Daphne Day, et al.
Gynecologic Oncology|September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancerAinhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Clinical Lung Cancer|October 31, 2013
A phase II trial of saracatinib, an inhibitor of src kinases, in previously-treated advanced non-small-cell lung cancer: the princess margaret hospital phase II consortiumScott A Laurie, Glenwood D Goss, Frances A Shepherd, et al.
Pageof 17